Literature DB >> 12801952

Severe idiopathic gastroparesis due to neuronal and interstitial cells of Cajal degeneration: pathological findings and management.

N Zárate1, F Mearin, X-Y Wang, B Hewlett, J D Huizinga, J-R Malagelada.   

Abstract

Delayed gastric emptying can be due to muscular, neural, or humoral abnormalities. In the absence of an identified cause, gastroparesis is labelled as idiopathic. We present the case of a patient with severe idiopathic gastroparesis. Pharmacological approaches failed, as well as reduction in gastric emptying resistance with pyloric injection of botulinum toxin and pyloroplasty. Therefore, subtotal gastrectomy was performed. Histological and immunohistochemical study of the resected specimen showed hypoganglionosis, neuronal dysplasia, and a marked reduction in both myenteric and intramuscular interstitial cells of Cajal. To our knowledge, this is the first time these rare histological findings have been described in a patient with idiopathic gastroparesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12801952      PMCID: PMC1773724          DOI: 10.1136/gut.52.7.966

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  28 in total

1.  Development of interstitial cells of Cajal in a full-term infant without an enteric nervous system.

Authors:  J D Huizinga; I Berezin; K Sircar; B Hewlett; G Donnelly; P Bercik; C Ross; T Algoufi; P Fitzgerald; T Der; R H Riddell; S M Collins; K Jacobson
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

2.  Decreased interstitial cell of cajal volume in patients with slow-transit constipation.

Authors:  C L He; L Burgart; L Wang; J Pemberton; T Young-Fadok; J Szurszewski; G Farrugia
Journal:  Gastroenterology       Date:  2000-01       Impact factor: 22.682

3.  Improved infusion system for intraluminal esophageal manometry.

Authors:  R C Arndorfer; J J Stef; W J Dodds; J H Linehan; W J Hogan
Journal:  Gastroenterology       Date:  1977-07       Impact factor: 22.682

4.  Loss of interstitial cells of cajal and inhibitory innervation in insulin-dependent diabetes.

Authors:  C L He; E E Soffer; C D Ferris; R M Walsh; J H Szurszewski; G Farrugia
Journal:  Gastroenterology       Date:  2001-08       Impact factor: 22.682

5.  Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis.

Authors:  T Ordög; I Takayama; W K Cheung; S M Ward; K M Sanders
Journal:  Diabetes       Date:  2000-10       Impact factor: 9.461

6.  Loss of interstitial cells and a fibromuscular layer on the luminal side of the colonic circular muscle presenting as megacolon in an adult patient.

Authors:  M S Faussone-Pellegrini; P Fociani; R Buffa; G Basilisco
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

7.  Physiological variations in canine gastric tone measured by an electronic barostat.

Authors:  F Azpiroz; J R Malagelada
Journal:  Am J Physiol       Date:  1985-02

8.  Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle.

Authors:  Larry S Miller; Gregory A Szych; Steven B Kantor; Matthew Q Bromer; Linda C Knight; Alan H Maurer; Robert S Fisher; Henry P Parkman
Journal:  Am J Gastroenterol       Date:  2002-07       Impact factor: 10.864

9.  Gastric and small intestinal myoelectric dysrhythmia associated with chronic intractable nausea and vomiting.

Authors:  C H You; W Y Chey; K Y Lee; R Menguy; A Bortoff
Journal:  Ann Intern Med       Date:  1981-10       Impact factor: 25.391

10.  Idiopathic intermittent gastroparesis and its surgical alleviation.

Authors:  P C Shellito; A L Warshaw
Journal:  Am J Surg       Date:  1984-09       Impact factor: 2.565

View more
  47 in total

Review 1.  The use of botulinum toxin for the treatment of gastrointestinal motility disorders.

Authors:  Frank Friedenberg; Satya Gollamudi; Henry P Parkman
Journal:  Dig Dis Sci       Date:  2004-02       Impact factor: 3.199

2.  Minimally invasive surgical approach for the treatment of gastroparesis.

Authors:  Joerg Zehetner; Farrokh Ravari; Shahin Ayazi; Afshin Skibba; Ali Darehzereshki; Diana Pelipad; Rodney J Mason; Namir Katkhouda; John C Lipham
Journal:  Surg Endosc       Date:  2012-06-30       Impact factor: 4.584

3.  Severe isolated myopathic gastroparesis: a case report with pathological findings.

Authors:  H Sokol; A Lavergne-Slove; J Mikol; J M Sabate; B Coffin
Journal:  Gut       Date:  2006-11       Impact factor: 23.059

4.  Loss of interstitial cells of Cajal network in severe idiopathic gastroparesis.

Authors:  Edda Battaglia; Gabrio Bassotti; Graziella Bellone; Luca Dughera; Anna-Maria Serra; Luigi Chiusa; Alessandro Repici; Pierroberto Mioli; Giorgio Emanuelli
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

Review 5.  Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years.

Authors:  Purna Kashyap; Gianrico Farrugia
Journal:  Gut       Date:  2010-09-25       Impact factor: 23.059

Review 6.  Gastroparesis--current concepts and considerations.

Authors:  William L Hasler
Journal:  Medscape J Med       Date:  2008-01-23

Review 7.  Gastrointestinal motility in acute illness.

Authors:  Sonja Fruhwald; Peter Holzer; Helfried Metzler
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

8.  Magnolol pretreatment prevents sepsis-induced intestinal dysmotility by maintaining functional interstitial cells of Cajal.

Authors:  Bin Miao; Shuwen Zhang; Hong Wang; Tiecheng Yang; Deshan Zhou; Bao-en Wang
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

Review 9.  Endoscopic botox injections in therapy of refractory gastroparesis.

Authors:  Andrew Ukleja; Kanwarpreet Tandon; Kinchit Shah; Alicia Alvarez
Journal:  World J Gastrointest Endosc       Date:  2015-07-10

10.  Tumor necrosis factor alpha derived from classically activated "M1" macrophages reduces interstitial cell of Cajal numbers.

Authors:  S T Eisenman; S J Gibbons; P-J Verhulst; G Cipriani; D Saur; G Farrugia
Journal:  Neurogastroenterol Motil       Date:  2016-10-25       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.